Form 8-K - Current report:
SEC Accession No. 0001513162-23-000023
Filing Date
2023-03-02
Accepted
2023-03-02 09:23:03
Documents
13
Period of Report
2023-03-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K bmra-20230301.htm   iXBRL 8-K 31013
  Complete submission text file 0001513162-23-000023.txt   167760

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bmra-20230301.xsd EX-101.SCH 3179
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bmra-20230301_def.xml EX-101.DEF 10555
4 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT bmra-20230301_lab.xml EX-101.LAB 19915
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bmra-20230301_pre.xml EX-101.PRE 10917
7 EXTRACTED XBRL INSTANCE DOCUMENT bmra-20230301_htm.xml XML 2443
Mailing Address 17571 VON KARMAN AVENUE IRVINE CA 92614
Business Address 17571 VON KARMAN AVENUE IRVINE CA 92614 9496452111
BIOMERICA INC (Filer) CIK: 0000073290 (see all company filings)

EIN.: 952645573 | State of Incorp.: DE | Fiscal Year End: 0531
Type: 8-K | Act: 34 | File No.: 001-37863 | Film No.: 23696675
SIC: 2835 In Vitro & In Vivo Diagnostic Substances